12
Jo Anne Zujewski, MD Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Division of Cancer Diagnosis and Treatment Treatment National Cancer Institute National Cancer Institute May 2011 May 2011 Breast Cancer Biology

Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

  • Upload
    calida

  • View
    32

  • Download
    1

Embed Size (px)

DESCRIPTION

Breast Cancer Biology. Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment National Cancer Institute May 2011. Breast Cancer Theory: Halsted. Operative breast cancer is a local-regional disease - PowerPoint PPT Presentation

Citation preview

Page 1: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Jo Anne Zujewski, MDJo Anne Zujewski, MDCancer Therapy Evaluation ProgramCancer Therapy Evaluation Program

Division of Cancer Diagnosis and TreatmentDivision of Cancer Diagnosis and TreatmentNational Cancer InstituteNational Cancer Institute

May 2011May 2011

Breast Cancer Biology

Page 2: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Breast Cancer Theory: Halsted

• Operative breast cancer is a local-regional disease• The positive lymph node is the source of distant

metastases

Page 3: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Breast Cancer Theory: Systemic

• Operative breast cancer is a systemic disease• Positive lymph node is an indicator of host-tumor

relationship that permits metastases

Page 4: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Breast Cancer Theory: Spectrum

• Operative breast cancer is a systemic disease in many but not all cases

• Positive lymph node is correlated with the subsequent appearance of distant metastases

Page 5: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Seminal observations that have Seminal observations that have led to the current understanding led to the current understanding

of breast cancer as a family of of breast cancer as a family of related diseases, not a single related diseases, not a single

monolithic process.”monolithic process.”

Page 6: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Molecular Portrait of Breast Cancers

HER-2Basal-like Luminal ALuminal B“Normal”

Sorlie T et al, PNAS 2001Slide courtesy of L. Carey

Page 7: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Subtypes and Prognosis

Sorlie T et al, PNAS 2001

Page 8: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Genetic FactorsGenetic Factors

Oncogenes

Tumor suppressor genes

DNA repair genes

Carcinogen activating/deactivating genes

Cell cycle genes

Cell cycle checkpoint genes

Cell death genes

Cell signaling genes

Cellular senescence genes

Cellular differentiation genes

Metastasis/invasion genes

Page 9: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Hormones Growth factors Small interfering RNAs Post-translational modifications

methylation protein ubiquination phosphorylation

Epigenetic Factors

Page 10: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Breast Cancer

a multi-step process

genetic changes

epigenetic changes

mutagenic/nonmutagenic

risk factors

gene signatures

Page 11: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

In pathways, messages are sent from the outside of the cell to the inside of the cell through messengers.

SIGNAL

TRANSDUCTION

Cells respond to external signals through pathways.

Page 12: Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment

Breast Cancer Development, Growth, Survival Breast Cancer Development, Growth, Survival and Metastasis Involves Multiple Interrelated and Metastasis Involves Multiple Interrelated

Pathways Pathways

Concurrent Concurrent targeting of targeting of

multiple multiple pathways pathways

will likely be will likely be optimal!!optimal!!